A-TEK receives CIO-SP3 government wide acquisition contract from NIH

NewsGuard 100/100 Score

A-TEK, Inc. announced today it has been awarded the National Institutes of Health (NIH) Chief Information Officer-Solutions and Partners 3 (CIO-SP3) Government Wide Acquisition Contract (GWAC). CIO-SP3 is valued at $20 billion with a 10-year term.    

CIO-SP3 is the successor contract to NIH's current Chief Information Officer Solutions and Partners 2 Innovations (CIO-SP2i) and the Image World2 New Dimensions (W2nd) GWACs. CIO-SP3 continues to support government Information Technology (IT) efforts with a focus on health and biomedical-related IT services in support of federal agencies health missions. There are ten (10) functional areas supported by CIO-SP3 to include: Chief Information Officer (CIO) Support, IT Operations and Maintenance, Critical Infrastructure and Information Assurance, Enterprise Resource Management, and Software Development.

"We are pleased to be among the awardees of the CIO-SP3 contract in all ten functional areas. This award allows A-TEK and its teaming partners of both large and small businesses, to continue supporting mission critical programs within the federal marketplace utilizing the CIO-SP3 vehicle," says Kathryn Freeland, A-TEK CEO. A-TEK is also a current CIO-SP2i contract holder.

Source:

A-TEK, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.